AWM Investment Company Inc. Boosts Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

AWM Investment Company Inc. grew its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 14.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 516,794 shares of the company’s stock after purchasing an additional 66,779 shares during the period. AWM Investment Company Inc. owned about 2.13% of OrthoPediatrics worth $11,979,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Millennium Management LLC bought a new position in shares of OrthoPediatrics in the fourth quarter worth about $9,798,000. Point72 Asset Management L.P. bought a new position in OrthoPediatrics in the 4th quarter worth about $7,450,000. Wasatch Advisors LP increased its position in shares of OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after acquiring an additional 223,217 shares during the period. Wellington Management Group LLP increased its position in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after acquiring an additional 178,078 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock valued at $15,576,000 after acquiring an additional 152,681 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Piper Sandler dropped their price objective on OrthoPediatrics from $40.00 to $30.00 and set an “overweight” rating on the stock in a research note on Thursday, May 8th. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Thursday, May 8th. Truist Financial decreased their price objective on OrthoPediatrics from $26.00 to $24.00 and set a “hold” rating for the company in a report on Friday, April 11th. Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 5th. Finally, Lake Street Capital began coverage on shares of OrthoPediatrics in a report on Monday, April 7th. They issued a “buy” rating and a $37.00 price target for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, OrthoPediatrics presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.83.

OrthoPediatrics Stock Down 0.3%

NASDAQ:KIDS opened at $22.89 on Wednesday. The company’s 50-day simple moving average is $22.77 and its 200-day simple moving average is $23.91. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics Corp. has a fifty-two week low of $20.25 and a fifty-two week high of $35.99. The stock has a market capitalization of $555.93 million, a P/E ratio of -18.61 and a beta of 1.09.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Wednesday, May 7th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.13). The firm had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. On average, equities analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In related news, insider Gregory A. Odle sold 5,359 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the completion of the transaction, the insider now directly owns 148,788 shares of the company’s stock, valued at $3,698,869.68. This trade represents a 3.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO David R. Bailey sold 6,620 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $164,573.20. Following the sale, the chief executive officer now directly owns 319,155 shares in the company, valued at approximately $7,934,193.30. This represents a 2.03% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 23,732 shares of company stock worth $589,978. 32.70% of the stock is owned by insiders.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.